Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-29 Option Award | 2024-03-04 9:20 pm | N/A 2034-02-28 | Prime Medicine Inc. | PRME | Marrazzo Jeffrey D Director | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2024-02-29 4:21 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2023 GP L.L.C. GV 2023 GP L.P. GV 2023 L.P. Alphabet Inc. Member of 10% Group | 0 | $0 | 3,200,000 (Indirect) | View |
| 2024-02-25 Option Award | 2024-02-27 09:35 am | N/A 2034-02-25 | Prime Medicine Inc. | PRME | Gottesdiener Keith Michael See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:04 pm | N/A 2034-02-21 | Prime Medicine Inc. | PRME | Brudnick Richard Chief Business Officer | 135,747 | $0 | 135,747 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:03 pm | N/A 2034-02-21 | Prime Medicine Inc. | PRME | Duffield Jeremy Chief Scientific Officer | 180,995 | $0 | 180,995 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:02 pm | N/A 2034-02-21 | Prime Medicine Inc. | PRME | LEE ANN L. Chief Technical Officer | 180,995 | $0 | 180,995 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:02 pm | N/A 2034-02-21 | Prime Medicine Inc. | PRME | Goldwasser Meredith SVP, Strategy & Corporate Ops. | 90,498 | $0 | 90,498 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:01 pm | N/A 2034-02-21 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 90,498 | $0 | 90,498 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:19 pm | N/A 2034-01-17 | Prime Medicine Inc. | PRME | Reine Allan Chief Financial Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2023-11-11 Gift | 2023-11-14 8:11 pm | N/A N/A | Prime Medicine Inc. | PRME | Gottesdiener Keith Michael See Remarks | 12,500 | $0 | 4,361,078 (Direct) | View |
| 2023-07-21 Gift(A) | 2023-07-26 08:29 am | N/A N/A | Prime Medicine Inc. | PRME | Liu David R. 10% Owner | 1,000,000 | $0 | 20,156,945 (Direct) | View |
| 2023-07-21 Gift | 2023-07-25 8:15 pm | N/A N/A | Prime Medicine Inc. | PRME | Liu David R. 10% Owner | 1,000,000 | $0 | 20,156,945 (Direct) | View |
| 2023-06-20 Other | 2023-06-22 5:03 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 56,408 | $0 | 1,818,848 (Indirect) | View |
| 2023-06-15 Other | 2023-06-20 4:17 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 73,191 | $0 | 1,835,631 (Indirect) | View |
| 2023-06-14 Option Award | 2023-06-16 5:51 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | Cahill Thomas Director | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:50 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | Schenkein David P Director | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:49 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | Foster-Cheek Kaye I Director | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:49 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:48 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | Kelly Michael Aaron Director | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:47 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | Chung Wendy Director | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-13 Other | 2023-06-15 4:22 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 57,060 | $0 | 1,819,500 (Indirect) | View |
| 2023-06-09 Other | 2023-06-13 4:20 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 31,703 | $0 | 1,794,143 (Indirect) | View |
| 2023-06-07 Other | 2023-06-09 4:24 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 20,000 | $0 | 1,782,440 (Indirect) | View |
| 2023-06-05 Other | 2023-06-07 4:17 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 52,409 | $0 | 1,814,849 (Indirect) | View |
| 2023-05-31 Other | 2023-06-02 4:17 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 61,856 | $0 | 1,824,296 (Indirect) | View |
| 2023-05-26 Other | 2023-05-31 4:15 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 29,407 | $0 | 1,791,847 (Indirect) | View |
| 2023-05-24 Other | 2023-05-26 4:17 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 31,061 | $0 | 1,793,501 (Indirect) | View |
| 2023-05-22 Other | 2023-05-24 5:07 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 131,861 | $0 | 1,894,301 (Indirect) | View |
| 2023-05-18 Other | 2023-05-22 4:21 pm | N/A N/A | Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner | 77,234 | $0 | 1,839,674 (Indirect) | View |
| 2023-05-10 Option Award | 2023-05-12 4:30 pm | N/A 2033-05-10 | Prime Medicine Inc. | PRME | Marrazzo Jeffrey D Director | 92,000 | $0 | 92,000 (Direct) | View |
| 2023-04-18 Option Award | 2023-04-20 4:28 pm | N/A 2033-04-18 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 6,254 | $0 | 6,254 (Direct) | View |